Dr. Evan M. Vapnek is a Board Certified Urologist and Kidney Transplant surgeon. In addition to being a founding member of Genesis Healthcare Partners, he is the Surgical Director of the Living Donor Program of the Sharp Memorial Kidney and Pancreas Transplant Program. He has been practicing in San Diego since 1999.
A native New Yorker, Dr. Vapnek received his undergraduate degree from the University of Rochester before earing his M.D. from the State University of New York, Health Science Center at Brooklyn. He completed two years of General Surgery training at University of California, San Francisco follow by a Urology residency at Downstate Medical Center. He then completed a two year fellowship in Renal Transplantation at the Cleveland Clinic Foundation.
He is a past president of the San Diego Urological Association and serves on the board for the Urologic Society for Transplant and Renal Surgery.
Dr. Vapnek is on staff at Sharp Memorial and Scripps Mercy hospitals. He treats all urologic conditions including kidney stones, enlarged prostate, urinary incontinence and has particular expertise in laparoscopic and robotic kidney surgery.
Urological Physicians of San Diego, a Division of Genesis Healthcare Partners
Surgical Director, Living Donor Transplant Program, Sharp Memorial Hospital Kidney-Pancreas Transplant Center
|1987 to 1991||State University of New York, Downstate Medical School
Brooklyn, New York
|1983 to 1987||University of Rochester
Rochester, New York
Degree: B.S., Biological Sciences: Neuroscience
Distinction in Research
|1997 to 1999||Department of Urology, Cleveland Clinic Foundation,
Cleveland, Ohio, Renal Transplantation and Renovascular
|1993 to 1997||Department of Urology, State University of New York
Health Science Center at Brooklyn, New York -
Post-graduate levels III - VI
|1991 to 1993||Department of Surgery, University of California,
San Francisco, California - Post-graduate levels I - II
LICENSURE AND CERTIFICATION
California #G 75357 exp. 1/31/12
Diplomate American Board of Urology, Certified 2001, exp. 2/28/2021
Sharp Memorial Hospital, San Diego, CA
Scripps Mercy Hospital, San Diego, CA
Sharp Coronado Hospital, Coronado, CA
AWARDS AND HONORS
New York Academy of Medicine, Ferdinand Valentine Fellowship for Urologic Research, July 1997-June 1998
2nd Prize - Clinical Division, Murray Freedman Essay Contest, American College of Surgeons, Brooklyn-Long Island Chapter, May 1994
Department of Urology, State University of New York Health Science Center at Brooklyn, Award for Highest Score on AUA In-Training Exam 1993, 1994, 1995, 1996.
- San Diego Urological Society, Past President
- American Urological Association
- Western Section, American Urological Association
- American Medical Association
- American Society of Transplantation
- Urologic Society for Transplantation and Vascular Surgery
|2008 - present||Vice Chairman, Urology Supervisory Committee, Sharp Memorial Hospital|
|2004||Chairman, Medical Advisory Committee, Lifesharing Organ Procurement Organization|
|2001 - present||Cancer Committee, Scripps Mercy Hospital|
- Kapoor A., Morita, K., Engeman, T., Koga, S., Hobart, M., Vapnek, E., and Fairchild, R. Early production of IFN-g induced chemokines in allogeneic heart grafts is mediated by CD8 T cells. Transplantation, Vol. 69, 2000: pp. 1147-1155
- Plawker, M.W., Fleisher, J.M., Vapnek, E.M., Macchia, R.J. Current Trends in Prostate Cancer Diagnosis and Staging Among United States Urologists, Journal of Urology, Vol. 158, No 5 (November) 1997: pp. 1853-1858.
- Bretan, P.N., Banfasche, R., Vapnek, E., Garavoy, M. Minimizing Recipient-Donor Size Differences Improves Long-Term Graft Survival Using Single Pediatric Cadaveric Kidneys. Transplantation Proceedings, Vol. 26, No 1 (February), 1994: pp. 28-29.
- Early Intra-Graft Expression of Chemokine Genes During Acute Rejection of Allogeneic Skin and Cardiac Grafts. American Urological Association, Urologic Society for Transplantation and Vascular Surgery, San Diego, CA, June 1998
- Early Intra-Graft Expression of Chemokine Genes During Acute Rejection of Allogeneic Cardiac Grafts.
American Society of Transplant Physicians, Chicago, IL, May 1998.